TuHURA BIOSCIENCES, INC./NV Income (Loss) from Continuing Operations, Per Basic and Diluted Share
TuHURA BIOSCIENCES, INC./NV (HURA) reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-07.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2012-02-07
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, per basic and diluted share for the quarter ending 2011-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV income (loss) from continuing operations, per basic and diluted share for the quarter ending 2010-12-31 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month |
|---|---|---|
| 2011-12-31 | $0.00 10-Q · filed 2012-02-07 | $0.00 10-Q · filed 2012-02-07 |
| 2010-12-31 | $0.00 10-Q · filed 2012-02-07 | -$0.02 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |